Effective Strategies for the Diagnosis and Treatment of Enteric Fever: A Comprehensive Guide for Healthcare Professionals
OthersPage Navigation
Introduction
Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant health concern worldwide. Early diagnosis and treatment are crucial in reducing morbidity and mortality.
Diagnosis
The gold standard for diagnosis is blood culture, providing definitive evidence of infection. However, due to its low sensitivity, other diagnostic methods such as Widal test and PCR have been utilized. Recent advancements include the Typhidot test and Tubex test, offering improved sensitivity and specificity.
Treatment
Antibiotic therapy remains the cornerstone of treatment. Fluoroquinolones were once the first-line therapy, but resistance has led to a shift towards third-generation cephalosporins and azithromycin. Patient management also involves supportive care, including hydration and fever management.
Prevention
Vaccination is the most effective preventive measure. Two vaccines, Vi polysaccharide vaccine (ViPS) and Ty21a, are currently available and provide substantial protection.
Conclusion
Effective strategies for enteric fever involve a combination of early diagnosis, appropriate antibiotic therapy, supportive care, and vaccination. Continued research into diagnostic methods and antibiotic resistance is essential.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge